312 related articles for article (PubMed ID: 33203098)
1. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
Colilla M; Vallet-Regí M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
[TBL] [Abstract][Full Text] [Related]
3. Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms.
Lu MM; Ge Y; Qiu J; Shao D; Zhang Y; Bai J; Zheng X; Chang ZM; Wang Z; Dong WF; Tang CB
Int J Nanomedicine; 2018; 13():7697-7709. PubMed ID: 30538453
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous Silica-Based Materials with Bactericidal Properties.
Bernardos A; Piacenza E; Sancenón F; Hamidi M; Maleki A; Turner RJ; Martínez-Máñez R
Small; 2019 Jun; 15(24):e1900669. PubMed ID: 31033214
[TBL] [Abstract][Full Text] [Related]
5. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
6. Antibiofilm activity of mesoporous silica nanoparticles against the biofilm associated infections.
Sil M; Mukherjee D; Goswami A; Nag M; Lahiri D; Bhattacharya D
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3617-3633. PubMed ID: 38051365
[TBL] [Abstract][Full Text] [Related]
7. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
[TBL] [Abstract][Full Text] [Related]
8. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
9. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica nanoparticles as diagnostic and therapeutic tools: how can they combat bacterial infection?
Şen Karaman D; Manner S; Rosenholm JM
Ther Deliv; 2018 Mar; 9(4):241-244. PubMed ID: 29495945
[No Abstract] [Full Text] [Related]
11. Organically Modified Mesoporous Silica Nanoparticles against Bacterial Resistance.
Colilla M; Vallet-Regí M
Chem Mater; 2023 Nov; 35(21):8788-8805. PubMed ID: 38027542
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
Baeza A; Manzano M; Colilla M; Vallet-Regí M
Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
[TBL] [Abstract][Full Text] [Related]
15. Electrospinning of silica nanoparticles-entrapped nanofibers for sustained gentamicin release.
Chen X; Xu C; He H
Biochem Biophys Res Commun; 2019 Sep; 516(4):1085-1089. PubMed ID: 31279530
[TBL] [Abstract][Full Text] [Related]
16. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
[TBL] [Abstract][Full Text] [Related]
17. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances Toward the Use of Mesoporous Silica Nanoparticles for the Treatment of Bacterial Infections.
Castillo RR; Vallet-Regí M
Int J Nanomedicine; 2021; 16():4409-4430. PubMed ID: 34234434
[TBL] [Abstract][Full Text] [Related]
19. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
[TBL] [Abstract][Full Text] [Related]
20. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
